C07D 233/20
With substituted hydrocarbon radicals, directly attached to ring carbon atoms
Official title: with substituted hydrocarbon radicals, directly attached to ring carbon atoms
C07D233/20 (With substituted hydrocarbon radicals, directly attached to ring carbon atoms) appears on 484 US grants and 373 published applications in this corpus.
Search patents in C07D- Granted patents
- 484
- Published applications
- 373
- Assignees
- 289
- Inventors
- 1,353
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 15 | 0 |
| 1977 | 18 | 0 |
| 1978 | 11 | 0 |
| 1979 | 8 | 0 |
| 1980 | 9 | 0 |
| 1981 | 9 | 0 |
| 1982 | 8 | 0 |
| 1983 | 6 | 0 |
| 1984 | 8 | 0 |
| 1985 | 6 | 0 |
| 1986 | 6 | 0 |
| 1987 | 9 | 0 |
| 1988 | 3 | 0 |
| 1989 | 7 | 0 |
| 1990 | 6 | 0 |
| 1991 | 8 | 0 |
| 1992 | 5 | 0 |
| 1993 | 8 | 0 |
| 1994 | 4 | 0 |
| 1995 | 6 | 0 |
| 1996 | 6 | 0 |
| 1997 | 4 | 0 |
| 1998 | 6 | 0 |
| 1999 | 11 | 0 |
| 2000 | 15 | 0 |
| 2001 | 9 | 4 |
| 2002 | 18 | 11 |
| 2003 | 11 | 23 |
| 2004 | 10 | 20 |
| 2005 | 12 | 23 |
| 2006 | 5 | 23 |
| 2007 | 14 | 23 |
| 2008 | 16 | 17 |
| 2009 | 12 | 24 |
| 2010 | 12 | 13 |
| 2011 | 15 | 14 |
| 2012 | 9 | 11 |
| 2013 | 15 | 11 |
| 2014 | 12 | 17 |
| 2015 | 11 | 13 |
| 2016 | 10 | 15 |
| 2017 | 17 | 18 |
| 2018 | 7 | 13 |
| 2019 | 9 | 10 |
| 2020 | 14 | 17 |
| 2021 | 6 | 13 |
| 2022 | 12 | 13 |
| 2023 | 6 | 11 |
| 2024 | 6 | 8 |
| 2025 | 7 | 3 |
| 2026 | 7 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Highly pure phentolamine mesylate and methods for making same15 Sep 2026US 12,735,389 B2Opus Genetics, Inc.
- Compounds for the treatment of bacterial infections and potentiation of antibiotics8 Sep 2026US 12,728,105 B2Georgia State University Research Foundation, Inc.
- α1A-adrenergic receptor agonists and methods of use1 Sep 2026US 12,723,038 B2CuraSen Therapeutics, Inc.
- Substituted pyrazolo[1,5-α]pyrimidines as CRF receptor antagonists21 Jul 2026US 12,686,680 B2Neurocrine Biosciences, Inc.
- Pourable wetting agents and methods associated therewith12 May 2026US 12,624,272 B2Saudi Arabian Oil Company
- Pourable wetting agents and methods associated therewith13 Aug 2026US 2026/0234462 A1Aramco Americas Company
- Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives16 Jul 2026US 2026/0200844 A1OrsoBio, Inc.
- Wellbore fluids including emulsifiers, and related methods9 Jul 2026US 2026/0193513 A1Schlumberger Technology Corporation
- Methods and materials for increasing level of phosphorylated ampk protein21 May 2026US 2026/0138955 A1University of Pittsburgh—Of the Commonwealth System of Higher Education
- Wellbore fluids including emulsifiers, and related methods12 Feb 2026US 2026/0042949 A1Schlumberger Technology Corporation
Most cited
By later US patents
- Mutilin derivatives and their use as antibacterials115US 7,534,814 B2Nabriva Therapeutics AG · 2009
- Heterocyclic compounds114US 4,742,060 ANihon Tokushu Noyaku Seizo K. K. · 1988
- Arylsulfonamido-substituted hydroxamic acids110US 5,455,258 ACiba-Geigy Corporation · 1995
- Arylsulfonamido-substituted hydroxamic acids85US 5,552,419 ACiba-Geigy Corporation · 1996
- Arylsufonamido-substituted hydroxamic acids78US 5,506,242 ACiba-Geigy Corporation · 1996